Tomorrow review
Tomorrow names its compounded preparations and separates monthly from quarterly semaglutide purchases. Its order-cancellation terms deserve equal attention.
The verdict
Tomorrow gives useful product detail, including glycine in its compounded semaglutide. The unresolved care question is how follow-up works for your state and treatment. Its public cancellation language is more restrictive for an initial order than the general cancel-anytime message suggests.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- From
- From $199/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Tomorrow offers compounded GLP-1 injections, lower-dose options and sublingual products, plus branded medicines. These are separate preparations, not interchangeable ways to obtain the same clinical result.
Who writes the prescription, and what do they see?
An independent medical group evaluates health information. A live phone or video consultation may be necessary depending on state requirements. A pharmacy, including VialsRX or another assigned dispenser, fills an appropriate prescription.
The site describes ongoing clinician oversight and account-based communication. Ask what follow-up is included before a refill, and which channel reaches the prescriber if side effects develop. The application cannot establish a guaranteed prescription.
What happens when the dose goes up?
The public offer describes clinician monitoring, but a lower-dose or sublingual preparation should not be substituted for a conventional injection without individual advice. Clarify the expected adjustment and refill schedule, including what happens during a treatment pause.
What the price includes
Semaglutide has separate monthly billing and a lower quarterly equivalent that requires an upfront package. Care and delivery are included in the stated product plan. Confirm the rate at your later prescribed dose and whether changing preparations changes the bundle.
What it claims, and what it cites
The semaglutide injection page identifies a compounded preparation with glycine. The broader catalog includes compounded tirzepatide and branded products. Finished compounded medicines are not FDA approved; evidence for an approved injection does not validate the sublingual alternatives.
Where it holds up, and where it does not
- Strength: Specific semaglutide formulation disclosed
- Strength: Independent medical review described
- Strength: Monthly and quarterly options separated
- Limitation: Initial order may become noncancelable at medical review
- Limitation: Product formats need distinct evidence
- Limitation: Follow-up timing not universal
What the evidence says about this kind of treatment
The assessment above is about Tomorrow. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A patient seeking a clearly described prescription option and willing to clarify ongoing clinical access.
- Wrong for
- Someone assuming a canceled subscription reverses an initial medical-review charge.
The evidence behind what Tomorrow prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Tomorrow compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: DadVantage Men's HealthDoctorAdamDollar Dad ClubDr. ArevitalizeDr. Gillis' Wellness CenterDrBrainRx
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Can a submitted initial order always be canceled?
- The terms say it cannot be canceled once submitted for medical review. Future renewals have separate cancellation controls.
- Does the quarterly equivalent offer monthly flexibility?
- No. The product page distinguishes quarterly upfront billing from its monthly purchase.
- Is Tomorrow expensive compared with other GLP-1 telehealth sellers?
- Tomorrow publishes a starting figure of $199/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Tomorrow above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Sources for this review
Provider information checked . Terms can change.